273 related articles for article (PubMed ID: 16307748)
1. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.
Su J; Georgiades A; Wu R; Thulin T; de Faire U; Frostegård J
Atherosclerosis; 2006 Sep; 188(1):160-6. PubMed ID: 16307748
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development.
Frostegård AG; Su J; Hua X; Vikström M; de Faire U; Frostegård J
PLoS One; 2014; 9(12):e111764. PubMed ID: 25473948
[TBL] [Abstract][Full Text] [Related]
3. Circulating oxidized low-density lipoprotein is increased in hypertension.
Frostegård J; Wu R; Lemne C; Thulin T; Witztum JL; de Faire U
Clin Sci (Lond); 2003 Nov; 105(5):615-20. PubMed ID: 12837127
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis.
Karvonen J; Päivänsalo M; Kesäniemi YA; Hörkkö S
Circulation; 2003 Oct; 108(17):2107-12. PubMed ID: 14530200
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
[TBL] [Abstract][Full Text] [Related]
6. Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.
Sämpi M; Ukkola O; Päivänsalo M; Kesäniemi YA; Binder CJ; Hörkkö S
J Am Coll Cardiol; 2008 Oct; 52(17):1370-8. PubMed ID: 18940525
[TBL] [Abstract][Full Text] [Related]
7. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.
Pereira I; Laurindo I; Burlingame R; Anjos L; Viana V; Leon E; Vendramini M; Borba E
Joint Bone Spine; 2008 Jul; 75(4):416-21. PubMed ID: 18457983
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to OxLDL are decreased in individuals with borderline hypertension.
Wu R; de Faire U; Lemne C; Witztum JL; Frostegård J
Hypertension; 1999 Jan; 33(1):53-9. PubMed ID: 9931081
[TBL] [Abstract][Full Text] [Related]
9. Measurement of plasma ox-LDL and carotid IMT may represent useful markers for atherosclerosis and may represent potential targets for therapeutic interventions.
Savoiu G; Drăgan S; Cristescu C; Serban C; Noveanus L; Ionescu D; Nicola T; Duicu O; Raducan A; Voicu M
Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):397-401. PubMed ID: 21491821
[TBL] [Abstract][Full Text] [Related]
10. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylcholine antibodies are diminished in ANCA-associated vasculitis.
Wilde B; Slot M; van Paassen P; Theunissen R; Kemna M; Witzke O; Cohen Tervaert JW
Eur J Clin Invest; 2015 Jul; 45(7):686-91. PubMed ID: 25940757
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis.
Wada Y; Kuroda T; Murasawa A; Tanabe N; Nakano M; Gejyo F
Clin Exp Rheumatol; 2005; 23(4):482-6. PubMed ID: 16095116
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia.
Tsouli SG; Kiortsis DN; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
Angiology; 2006; 57(5):615-22. PubMed ID: 17067985
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men.
Hulthe J; Bokemark L; Fagerberg B
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):101-7. PubMed ID: 11145940
[TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
Anania C; Gustafsson T; Hua X; Su J; Vikström M; de Faire U; Heimbürger M; Jogestrand T; Frostegård J
Arthritis Res Ther; 2010; 12(6):R214. PubMed ID: 21092251
[TBL] [Abstract][Full Text] [Related]
17. Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men.
Gigante B; Leander K; Vikström M; Baldassarre D; Veglia F; Strawbridge RJ; McLeod O; Gertow K; Sennblad B; Shah S; Zabaneh D; Humphries SE; Kauhanen J; Rauramaa R; Smit AJ; Mannarino E; Giral P; Tremoli E; Hamsten A; Frostegård J; de Faire U;
Atherosclerosis; 2014 Oct; 236(2):394-9. PubMed ID: 25150937
[TBL] [Abstract][Full Text] [Related]
18. Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.
Nowak B; Szmyrka-Kaczmarek M; Durazińska A; Płaksej R; Borysewicz K; Korman L; Wiland P
Adv Clin Exp Med; 2012; 21(3):331-5. PubMed ID: 23214196
[TBL] [Abstract][Full Text] [Related]
19. IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL.
Fiskesund R; Su J; Bulatovic I; Vikström M; de Faire U; Frostegård J
Results Immunol; 2012; 2():13-8. PubMed ID: 24371562
[TBL] [Abstract][Full Text] [Related]
20. Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease.
Fredrikson GN; Hedblad B; Berglund G; Alm R; Nilsson JA; Schiopu A; Shah PK; Nilsson J
Stroke; 2007 May; 38(5):1495-500. PubMed ID: 17363723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
